Contacts

92 Bowery St., NY 10013

thepascal@mail.com

+1 800 123 456 789

What an incredible three days at the 8th World Bronchiectasis Conference in Brisbane!

PCD Australia was proud to be part of an inspiring program filled with learning, collaboration, and advocacy. It was a true honour for our President, Catherine Kruljac to co-chair the first-ever dedicated PCD track alongside Dr. Claire Hogg and Phil Robinson. The session addressed key topics including diagnosis, molecular diagnostics, genotypic disparities, Indigenous health, pregnancy and delivery, and novel therapies—marking a significant milestone for the PCD community.

Catherine also participated in “A Hands-On, Patient-First Approach: Clearing the Airways with OPEP Therapy” with Prof Lucy Morgan , Annemarie Lee , and Sonia Cheng . The session demonstrated real patient case studies and OPEP therapy initiation, followed by a dynamic panel discussion. A sincere thank you to @TrudellMedicalInternational for sponsoring the session and to Antoine Mousnier David Sydor and Sonya Gilpin for being such a supportive and engaged team throughout the conference.

On the final day, PCD Australia Board Member Rebecca Borrington took part in a future-focused panel discussion exploring what the next five years should look like in bronchiectasis care. We were encouraged by the strong attention given to PCD among the panel and audience—a clear sign that our message is being heard.

We also extend our warmest congratulations to Ellie Maas , recipient of the David Serisier Rising Star Award, recognising her outstanding PhD research on the genetic characterisation of Australia’s largest primary ciliary dyskinesia cohort. This award honours the legacy of Associate Professor David Serisier, a pioneer in respiratory medicine and an enduring advocate for lung health.

A heartfelt thank you to our wonderful volunteers – John Bachman , Lara Lou, Stephanie March and Robyn Doyle who helped run the PCD Australia stand. Your time, passion, and dedication helped drive meaningful conversations and strengthen our visibility in the broader respiratory health community.

Our sincere thanks to Lung Foundation Australia, Prof Lucy Morgan , Associate Prof Lucy Barr Rachel Thomson and Lena Group for delivering such a professionally run and impactful event. We leave WBC 2025 inspired, connected, and more determined than ever to continue advocating for those living with PCD.

Recent Posts